Cargando…

4547 Understanding the molecular mechanism of natural killer cell deficiency to improve natural killer cell in vitro differentiation for therapeutics

OBJECTIVES/GOALS: Natural killer (NK) cells are a potential cancer therapeutic but expanding NK cells efficiently in vitro is difficult. Natural killer cell deficiency (NKD), a primary immune deficiency affecting only NK cells, is caused by defects in several DNA replication proteins. By studying NK...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmit, Megan, Baxley, Ryan, Mace, Emily, Orange, Jordan, Miller, Jeffery, Bielinsky, Anja-Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823218/
http://dx.doi.org/10.1017/cts.2020.101
_version_ 1784646756765532160
author Schmit, Megan
Baxley, Ryan
Mace, Emily
Orange, Jordan
Miller, Jeffery
Bielinsky, Anja-Katrin
author_facet Schmit, Megan
Baxley, Ryan
Mace, Emily
Orange, Jordan
Miller, Jeffery
Bielinsky, Anja-Katrin
author_sort Schmit, Megan
collection PubMed
description OBJECTIVES/GOALS: Natural killer (NK) cells are a potential cancer therapeutic but expanding NK cells efficiently in vitro is difficult. Natural killer cell deficiency (NKD), a primary immune deficiency affecting only NK cells, is caused by defects in several DNA replication proteins. By studying NKD we will achieve better NK cell in vitro differentiation. METHODS/STUDY POPULATION: One patient with NKD has a compound heterozygous mutation in the essential DNA replication protein MCM10. We hypothesize that in individuals with NKD, dramatic telomere erosion from abnormal DNA replication leads to premature senescence and the loss of NK cells. To test our hypothesis, we will knockout one allele of MCM10 or over express MCM10 in NK cells isolated from blood. We will then monitor telomere length, expansion and cytotoxic activity of these NK cells. To understand the role of MCM10 in early stages of NK cell development we will deplete MCM10 in induced pluripotent stem cells and differentiate these cells into NK cells. During this differentiation we will monitor progression through NK cell developmental stages as well as telomere length and senescence markers. RESULTS/ANTICIPATED RESULTS: Telomeres insulate chromosomes and induce permanent growth arrest (senescence) when they are critically short. We have demonstrated that depletion of a DNA replication protein causes telomere erosion and increases senescence markers. NK cells have shorter telomeres and lower telomerase expression than other immune cells. We predict, this relatively poor telomere maintenance sensitizes NK cells to telomere loss upon depletion of replication proteins. During in vitro differentiation, we expect NK cell precursors to undergo premature senescence secondary to telomere shortening. Furthermore, we expect supplementation of DNA replication proteins will enhance NK cell expansion and maturation. DISCUSSION/SIGNIFICANCE OF IMPACT: NKD patients have provided the scientific community with clues as to what proteins NK cells rely on for their development. This project aims not only to understand why these proteins are critical, but to harness that information for cellular anti-cancer therapeutics.
format Online
Article
Text
id pubmed-8823218
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-88232182022-02-18 4547 Understanding the molecular mechanism of natural killer cell deficiency to improve natural killer cell in vitro differentiation for therapeutics Schmit, Megan Baxley, Ryan Mace, Emily Orange, Jordan Miller, Jeffery Bielinsky, Anja-Katrin J Clin Transl Sci Basic Science/Methodology OBJECTIVES/GOALS: Natural killer (NK) cells are a potential cancer therapeutic but expanding NK cells efficiently in vitro is difficult. Natural killer cell deficiency (NKD), a primary immune deficiency affecting only NK cells, is caused by defects in several DNA replication proteins. By studying NKD we will achieve better NK cell in vitro differentiation. METHODS/STUDY POPULATION: One patient with NKD has a compound heterozygous mutation in the essential DNA replication protein MCM10. We hypothesize that in individuals with NKD, dramatic telomere erosion from abnormal DNA replication leads to premature senescence and the loss of NK cells. To test our hypothesis, we will knockout one allele of MCM10 or over express MCM10 in NK cells isolated from blood. We will then monitor telomere length, expansion and cytotoxic activity of these NK cells. To understand the role of MCM10 in early stages of NK cell development we will deplete MCM10 in induced pluripotent stem cells and differentiate these cells into NK cells. During this differentiation we will monitor progression through NK cell developmental stages as well as telomere length and senescence markers. RESULTS/ANTICIPATED RESULTS: Telomeres insulate chromosomes and induce permanent growth arrest (senescence) when they are critically short. We have demonstrated that depletion of a DNA replication protein causes telomere erosion and increases senescence markers. NK cells have shorter telomeres and lower telomerase expression than other immune cells. We predict, this relatively poor telomere maintenance sensitizes NK cells to telomere loss upon depletion of replication proteins. During in vitro differentiation, we expect NK cell precursors to undergo premature senescence secondary to telomere shortening. Furthermore, we expect supplementation of DNA replication proteins will enhance NK cell expansion and maturation. DISCUSSION/SIGNIFICANCE OF IMPACT: NKD patients have provided the scientific community with clues as to what proteins NK cells rely on for their development. This project aims not only to understand why these proteins are critical, but to harness that information for cellular anti-cancer therapeutics. Cambridge University Press 2020-07-29 /pmc/articles/PMC8823218/ http://dx.doi.org/10.1017/cts.2020.101 Text en © The Association for Clinical and Translational Science 2020 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Basic Science/Methodology
Schmit, Megan
Baxley, Ryan
Mace, Emily
Orange, Jordan
Miller, Jeffery
Bielinsky, Anja-Katrin
4547 Understanding the molecular mechanism of natural killer cell deficiency to improve natural killer cell in vitro differentiation for therapeutics
title 4547 Understanding the molecular mechanism of natural killer cell deficiency to improve natural killer cell in vitro differentiation for therapeutics
title_full 4547 Understanding the molecular mechanism of natural killer cell deficiency to improve natural killer cell in vitro differentiation for therapeutics
title_fullStr 4547 Understanding the molecular mechanism of natural killer cell deficiency to improve natural killer cell in vitro differentiation for therapeutics
title_full_unstemmed 4547 Understanding the molecular mechanism of natural killer cell deficiency to improve natural killer cell in vitro differentiation for therapeutics
title_short 4547 Understanding the molecular mechanism of natural killer cell deficiency to improve natural killer cell in vitro differentiation for therapeutics
title_sort 4547 understanding the molecular mechanism of natural killer cell deficiency to improve natural killer cell in vitro differentiation for therapeutics
topic Basic Science/Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823218/
http://dx.doi.org/10.1017/cts.2020.101
work_keys_str_mv AT schmitmegan 4547understandingthemolecularmechanismofnaturalkillercelldeficiencytoimprovenaturalkillercellinvitrodifferentiationfortherapeutics
AT baxleyryan 4547understandingthemolecularmechanismofnaturalkillercelldeficiencytoimprovenaturalkillercellinvitrodifferentiationfortherapeutics
AT maceemily 4547understandingthemolecularmechanismofnaturalkillercelldeficiencytoimprovenaturalkillercellinvitrodifferentiationfortherapeutics
AT orangejordan 4547understandingthemolecularmechanismofnaturalkillercelldeficiencytoimprovenaturalkillercellinvitrodifferentiationfortherapeutics
AT millerjeffery 4547understandingthemolecularmechanismofnaturalkillercelldeficiencytoimprovenaturalkillercellinvitrodifferentiationfortherapeutics
AT bielinskyanjakatrin 4547understandingthemolecularmechanismofnaturalkillercelldeficiencytoimprovenaturalkillercellinvitrodifferentiationfortherapeutics